It is brutal and very expensive to bring a new transcatheter valve to market. Boston Scientific invested vast amounts of resources to bring the Lotus transcatheter aortic valve replacement (TAVR) device to the U.S. market. However, the vendor found the Lotus lagged so far behind the first-to-market TAVR valves (the Edwards Lifesciences Sapien and the Medtronic CoreValve) that it was not worth further investment and removed the Lotus from the market in November 2020.

Some of the top technology news from ACC 2021. Top left, the LAAOS III trial showed benefit when surgeons seal off the LAA during other open heart procedures. Bottom left, the ReCor Paradise renal denervation system helped lower blood pressure in patients who did not respond to medication. Top right, for patients with both heart failure and AFib it makes no differences is therapy is focused on controlling the heart rhythm or heart rate. Bottom right, the FLOWER-MI trial found no benefit to FFR-guided PCI.

Here are the top 10 takeaways from the late-breaking studies on cardiovascular technologies presented at the 2021 American College of Cardiology (ACC) scientific sessions. 

June 7, 2021 — A couple years ago a study showed a mortality safety signal in patients who underwent peripheral artery disease (PAD) revascularization with paclitaxel drug-coated devices. This immediately raised alarm in with the U.S. Food and Drug Administration (FDA) and the interventional community and prompted numerous studies to confirm if there was a mortality signal, or if the findings were just coincidence.

June 7, 2021 — Edwards Lifesciences recently announced that clinical results from the company's transcatheter mitral and tricuspid programs, presented as part of the late-breaking clinical trials at EuroPCR and ACC 2021. Both valve programs demonstrated positive outcomes for patients impacted by mitral or tricuspid heart valve disease.

June 7, 2021 — The COVID-19 pandemic has taken a significant toll on cardiovascular clinicians, many of whom provide direct care to patients with or at greater risk of the virus. As a result, the prevalence of burnout among cardiovascular professionals nearly doubled when comparing pre- to peak COVID-19 pandemic levels. This was according to late-breaking results of American College of Cardiology (ACC) 2020 Well-Being Study presented at the 2021 ACC annual meeting in May.

June 3, 2021 — Medical imaging AI specialist Avicenna.AI announced that it has received certification in the United States and European Union for Cina Chest, its new artificial intelligence (AI) solution that leverages deep learning algorithms for emergency triage of deadly vascular conditions

Baystate Health is an integrated healthcare system serving more than 800,000 people throughout western New England. With roots dating back to 1883, Baystate Health has provided high-quality healthcare for more than 140 years.

Vaccinations appear to to be helping reduce COVID-19 virus positive case numbers, and a review of the U.S. COVID positive testing data data shows holiday gatherings played a key role in the virus spread.

June 3, 2020 — GE Healthcare is collaborating with the American College of Cardiology (ACC) through support of and participation in the ACC’s Applied Health Innovation Consortium for the purpose of building a roadmap for artificial intelligence (AI) and digital technology in cardiology and developing new strategies for improved health outcomes

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now